1. Home
  2. SCLX vs LOAN Comparison

SCLX vs LOAN Comparison

Compare SCLX & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • LOAN
  • Stock Information
  • Founded
  • SCLX 2011
  • LOAN 1989
  • Country
  • SCLX United States
  • LOAN United States
  • Employees
  • SCLX N/A
  • LOAN N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • LOAN Real Estate Investment Trusts
  • Sector
  • SCLX Health Care
  • LOAN Real Estate
  • Exchange
  • SCLX Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • SCLX 72.5M
  • LOAN 61.4M
  • IPO Year
  • SCLX N/A
  • LOAN 1999
  • Fundamental
  • Price
  • SCLX $0.45
  • LOAN $5.67
  • Analyst Decision
  • SCLX Strong Buy
  • LOAN
  • Analyst Count
  • SCLX 3
  • LOAN 0
  • Target Price
  • SCLX $11.33
  • LOAN N/A
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • LOAN 20.8K
  • Earning Date
  • SCLX 03-11-2025
  • LOAN 03-10-2025
  • Dividend Yield
  • SCLX N/A
  • LOAN 8.11%
  • EPS Growth
  • SCLX N/A
  • LOAN 6.53
  • EPS
  • SCLX N/A
  • LOAN 0.49
  • Revenue
  • SCLX $55,152,000.00
  • LOAN $7,394,068.00
  • Revenue This Year
  • SCLX $32.77
  • LOAN N/A
  • Revenue Next Year
  • SCLX $50.71
  • LOAN N/A
  • P/E Ratio
  • SCLX N/A
  • LOAN $11.57
  • Revenue Growth
  • SCLX 9.41
  • LOAN 5.79
  • 52 Week Low
  • SCLX $0.38
  • LOAN $4.60
  • 52 Week High
  • SCLX $2.63
  • LOAN $5.90
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 42.08
  • LOAN 57.76
  • Support Level
  • SCLX $0.40
  • LOAN $5.30
  • Resistance Level
  • SCLX $0.53
  • LOAN $5.70
  • Average True Range (ATR)
  • SCLX 0.05
  • LOAN 0.12
  • MACD
  • SCLX 0.01
  • LOAN 0.00
  • Stochastic Oscillator
  • SCLX 47.59
  • LOAN 74.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: